Navigation Links
Spectral announces 2008 financial results
Date:3/12/2009

ing of year (2,687) (1,021) ---------------------------- Deficit - End of year (4,189) (2,687) ---------------------------- ---------------------------- Basic and diluted loss per common share (0.06) (0.07) ---------------------------- ---------------------------- Weighted average number of common shares outstanding 24,118,424 24,117,333 ---------------------------- ---------------------------- Spectral Diagnostics Inc. Statements of Cash Flows For the years ended December 31, 2008 and 2007 ------------------------------------------------------------------------- (in thousands of dollars) 2008 2007 $ $ Cash provided by (used in) Operating activities Loss and comprehensive loss for the year (1,502) (1,666) Items not affecting cash Amortization 592 536 Amortization of commercial instruments included in cost of sales 76 63 Loss on disposal of property, plant and equipment - 46 Writeoff of purchased technology and trademarks - 66 Stock-based compensation expense 110 117 Interest on convertible note payable 164 165 Changes in non-cash working capit
'/>"/>
SOURCE Spectral Diagnostics Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Spectral signs exclusive license agreement to bring sepsis therapeutic to the U.S. market
2. Surface plasmon resonances of metal nanoparticles in array can have narrower spectral widths
3. Spectral announces third quarter 2008 results
4. Spectral to bring anti-sepsis therapy to the U.S. market
5. Spectral announces exclusive distribution agreement in Russia for its EAA(TM) Sepsis Diagnostic Assay
6. Spectral announces continuing support for the combination of EAA(TM) and anti-endotoxin therapeutics
7. Spectral announces presentation of data on improving sepsis patient management with EAA(TM) and Toraymyxin(TM) combination
8. Spectral and Toray expand collaboration to include new geographic territories
9. Spectrals EAA(TM) to be used in Phase III study for a sepsis anti-endotoxin therapy
10. Spectral announces new findings on the effectiveness of EAA(TM)/Toraymyxin(TM) at the 28th International Symposium on Intensive Care and Emergency Medicine
11. Spectral announces 2007 financial results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... DTS Language Services, Inc . is pleased to ... Science organizations who need document translations. Clients will now ... documents in advance with a selection of nearly 50 life ... a critical factor in clinical and scientific fields, and decrease ...
(Date:1/14/2014)... Date: Friday, April 11, 2014 , Time: ... 1360 Almshouse Road, Warrington, Pa. , Details: The ... to finding a cure for hepatitis B and improving the ... annual Crystal Ball on Friday, April 11 at Warrington Country ...
(Date:1/14/2014)... January 14, 2014 EquitiesIQ, a leading ... (OTCQB: ALQA). Alliqua is an emerging biomedical company acquiring, ... wound care market. , Free report download: http://equitiesiq.com/reports/alliqua/ ... a seasoned management team and Board, which launched the ...
(Date:1/14/2014)... 2014  RXi Pharmaceuticals Corporation (OTCQX: RXII), a biotechnology ... therapies addressing major unmet medical needs using RNA-targeted ... of Allowance from the United States Patent and ... (sd-rxRNA®), for the treatment of fibrosis. The patent ...
Breaking Biology Technology:DTS Improves Efficiency for Life Science Document Translations 2Hepatitis B Foundation to Host Annual Crystal Ball Gala 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 3
... 21 CV Therapeutics,Inc. (Nasdaq: CVTX ) announced ... for presentation at the American Heart,Association (AHA) Scientific Sessions ... November 8 - 12, 2008., In addition, company ... will present The Industry,s Perspective on the Pressures,Challenges and ...
... Postpones Special Meeting of Shareholders until further notice, RICHMOND, ... follow-on biologics and biopharmaceuticals, today,announced that on Thursday, October 16, ... Effective immediately, NASDAQ has suspended the enforcement of the rules ... bid price. -- Effective immediately, NASDAQ has also ...
... 21 Perceptive Informatics, the,industry,s leading eClinical technology ... PRXL ), today announced the,release of an ... (EDC) and Clinical Data Management System (CDMS) solution ... studies. The enhanced,4.3 version of the DataLabs EDC ...
Cached Biology Technology:CV Therapeutics Announces Presentations at American Heart Association Scientific Sessions 2008 2CV Therapeutics Announces Presentations at American Heart Association Scientific Sessions 2008 3Insmed Announces That NASDAQ Temporarily Suspends Minimum Bid Closing Price Rule 2Insmed Announces That NASDAQ Temporarily Suspends Minimum Bid Closing Price Rule 3Perceptive Informatics Improves Efficiency and Clinical Data Quality With Enhanced Version of EDC System 2Perceptive Informatics Improves Efficiency and Clinical Data Quality With Enhanced Version of EDC System 3Perceptive Informatics Improves Efficiency and Clinical Data Quality With Enhanced Version of EDC System 4Perceptive Informatics Improves Efficiency and Clinical Data Quality With Enhanced Version of EDC System 5Perceptive Informatics Improves Efficiency and Clinical Data Quality With Enhanced Version of EDC System 6
(Date:4/17/2014)... news release is available in German . ... us to recognise objects; they also provide us with a ... run, turn around, fall or sit still in a car ... motion trace on our retinas. Seemingly without effort, our brain ... maintain a stable position and a steady gaze during our ...
(Date:4/17/2014)... If a restaurant ... he can expect his premises to be trashed. Warnings like ... is enough to make restaurant owners pay up. Similarly, mafia-like ... in other birds, nests. If the host birds throw the ... destroying the entire nest. Consequently, it is beneficial for hosts ...
(Date:4/17/2014)... recent Yokahama IPCC meeting painted a stark warning on ... which has a greenhouse effect 32 times that of ... shown that humic substances act as fully regenerable electron ... are held in wetlands instead of being released to ... system is disrupted it may enter into a vicious ...
Breaking Biology News(10 mins):How vision makes sure that little fish do not get carried away 2How vision makes sure that little fish do not get carried away 3How vision makes sure that little fish do not get carried away 4Fear of the cuckoo mafia 2Fear of the cuckoo mafia 3Methane climate change risk suggested by proof of redox cycling of humic substances 2
... Far removed from streams of gas-thirsty cars and pollution-belching ... Circling the northern hemisphere, the conifer-dominated boreal forests ... act as a vast natural regulator of atmospheric carbon ... are studying how environmental factors such as forest fires ...
... MD - The November 1st and November 15th issues of ... online. Topics of interest include voltage-gated potassium channels that ... lipid rafts in cells, and the structure of a Na+/H+ ... 1, 2007 Dynamics of the Kv1.2 voltage-gated ...
... -- Researchers have discovered the secrets to enhancing ... A three-year study entitled "Greener Voices" proves that ... given responsibility for decision making and planning. ... two decades. Gardens are popping up in schools, ...
Cached Biology News:Wildfire drives carbon levels in northern forests 2Media highlights in the November issues of Biophysical Journal 2Media highlights in the November issues of Biophysical Journal 3Children's gardens mushrooming 2
Human peripheral blood PBMCs, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood PBMC and T Cells...
Umbilical cord blood mononuclear cells, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood MNCs and T Cells...
Umbilical cord blood basophils, For immunohistochemistry (IHC)...
Umbilical cord blood CD4+ T cells, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood MNCs and T Cells...
Biology Products: